Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase I/II Study to Evaluate the Safety and Immunogenicity of 'MG1109(Egg-based, Pre-pandemic Influenza(H5N1) Vaccine)' Administered Intramuscularly in Healthy Adult Volunteers

NCT01389466 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT01389466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01389466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase I/II Study to Evaluate the Safety and Immunogenicity of 'MG1109(Egg-based, Pre-pandemic Influenza(H5N1) Vaccine)' Administered Intramuscularly in Healthy Adult Volunteers
Lead sponsor
Green Cross Corporation
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2010
Completion date
December 31, 2011
Enrollment
346 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

influenza